|
Volumn 55, Issue 512, 2005, Pages 171-172
|
N-of-1 trials: An opportunity to tailor treatment in individual patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOOXYGENASE 2 INHIBITOR;
DEXAMPHETAMINE;
DRUG;
IBUPROFEN;
METHYLPHENIDATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PLACEBO;
QUININE;
THEOPHYLLINE;
ATTENTION DEFICIT DISORDER;
AWARENESS;
BIOEQUIVALENCE;
CAREGIVER;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL PRACTICE;
CLINICAL STUDY;
CLINICAL TRIAL;
CONSULTATION;
COST EFFECTIVENESS ANALYSIS;
DRUG PREFERENCE;
DRUG USE;
EDITORIAL;
GENOME ANALYSIS;
HEALTH CARE DELIVERY;
HEALTH MAINTENANCE ORGANIZATION;
HUMAN;
INTERMETHOD COMPARISON;
LEG CRAMP;
LONG TERM CARE;
MEDICAL DECISION MAKING;
NIGHT;
OSTEOARTHRITIS;
PATIENT COMPLIANCE;
PATIENT PARTICIPATION;
PERCEPTION;
PRIMARY MEDICAL CARE;
RISK BENEFIT ANALYSIS;
SELF REPORT;
SIDE EFFECT;
STANDARD;
TREATMENT OUTCOME;
TREATMENT PLANNING;
|
EID: 14944345311
PISSN: 09601643
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (14)
|
References (12)
|